Li, Chen
Ni, Wenjie
Wang, Xin
Zhou, Zongmei
Deng, Wei
Chang, Xiao
Chen, Dongfu
Feng, Qinfu
Liang, Jun
Wang, Xiaozhen
Deng, Lei
Wang, Wenqing
Bi, Nan
Zhang, Tao
Xiao, Zefen
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2016L04)
Capital Health Research and Development Special Fund (2016-2-4021)
Article History
Received: 9 November 2018
Accepted: 4 March 2019
First Online: 15 March 2019
Ethics approval and consent to participate
: Institutional review board approval was obtained for this trial from the ethical committee of the Chinese Academy of Medical Sciences (reference number CH-GI-067). This trial is also published under NCT02429622 on ExternalRef removed. Written informed consent is obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.